CYP1A1 and prostate carcinoma: Though previous research has failed to demonstrate a role for PAH-DNA adducts as a cancer factor in the prostate [6, 7], our results showing that prostate cancer has high CYP1A1 expression as compared to normal/benign prostate tissues suggests that CYP1A1 may contribute to prostate cancer pathogenesis.